I’ve decided to share the research found from the ALZHEIMER’S SURVIVAL study. I’ll be using the findings to create a list of all the ways I’ve been successful since I was diagnosed with ALS. I hope that one day people will look back at my research and decide to make the most out of their lives by living more fully and engaging in life.
Ive been trying to think of a way to explain it to people that would make it easy to understand. My goal has always been to raise ALS awareness and to help get people to make more informed decisions on their ALS-related health care. With ALS, there is always a risk that someone will die.
When I first heard about ALS, I was worried, but I also knew it was really serious. People with ALS are faced with the constant threat of being “wiped out.” We all know that the odds of becoming disabled before your time are extremely rare, but we also know that those without ALS can live a long time. When I was diagnosed, I was told that my chances of becoming disabled before my time were like winning the lottery.
The problem is that we just don’t know how long ALS patients can live. One estimate puts the median survival time at two years. That said, it’s probably better to live long enough to get better.
The good news is that there are a lot of new treatments and options to help people with ALS. And the bad news is that there are still a lot of patients who have to be put on a long list. But the good news is that the chances of becoming disabled before your time are extremely rare.
Alzheimer’s disease is a progressive neurodegenerative disease that causes a person’s memory, thinking, and behavior to fall dramatically by the end of their lives. But there is now a treatment: a drug called riluzole. The drug is taken before the patient is admitted to the hospital for treatment and after the patient has died.
The drug, riluzole, works by causing the brain cells in the patients’ gray matter to die off. That means they no longer produce the chemicals that make them able to think etc. After being treated, people can even walk around for a few days, but it’s a very slow process.
The drug is being funded by a consortium of pharmaceutical firms, including Bristol Myers Squibb, Eli Lilly, and GlaxoSmithKline. The way the drug is being developed is to first study patients who have been admitted to the hospital from a stroke.
This may sound a little sensationalist, but I am actually quite impressed with the way the drug is being developed. All of the companies involved are very smart and are trying to develop drugs that may be useful across a number of diseases. This is a very promising and exciting area for medicine.
That is exactly what will happen when a drug is tested on the actual patient. And it’s not just the pharmaceutical companies that are taking the risk. The FDA is going to be watching this. The FDA is going to want to know if the drug is working and if the patient is doing well. This will be the most critical thing they look at before deciding whether to approve the drug.